SkinBioTherapeutics plc (SBTX.L)
SkinBioTherapeutics plc, a life science company, engages in research and development, and commercialization of technology that harnesses the microbiome for human health in the United Kingdom, the United States, Europe, and internationally.
11.11-0.05%Healthcare
StockGlow Score
Leaning Bullish
BearishBullish
1 year ago-33.7%
The outlook
SkinBioTherapeutics plc currently reads as leaning bullish based on above its 50- & 200-day averages, 48% of the way from its 52-week low to high, avg target +161% vs current price. This is a snapshot of current market data, not a forecast.
What’s behind the score
Price trendAbove its 50- & 200-day averages
52-week range48% of the way from its 52-week low to high
Price targetAvg target +161% vs current price
Market cap
$28.8M
52-wk high
23.00
52-wk low
0.10
50-day avg
9.40
200-day avg
11.02
Trailing P/E
—